3 results
Approved WMOCompleted
The primary efficacy endpoint is treatment success in the therapy for mild to moderate Crohn*s disease with fisultas defined by: - A reduction of at least 50% in the number of draining fistulas at both week 4 and week 8
Approved WMORecruiting
To determine the microbiological and clinical cure rate after 14 days.
Approved WMOCompleted
To assess whether patients receiving simple hallux valgus surgery ambulate independently earlier after spinal anesthesia combined with LIA, compared to popliteal blocks. We hypothesize that both groups will demonstrate sufficient pain relief.